[Featured Stock] SK Chemicals Rises 22% on AstraZeneca Supply Contract Agreement

On the 21st, SK Chemicals is showing strong performance.

As of 9:14 AM on the same day, SK Chemicals' stock price is trading at 79,500 KRW, up 22.50% compared to the previous trading day. This surge appears to be driven by investor interest following the announcement of a contract with multinational pharmaceutical company AstraZeneca for the contract manufacturing and supply of the diabetes combination drug 'Cidaphvia'.

Under this contract, SK Chemicals will manufacture and supply Cidaphvia on a contract basis until December 31, 2029.

In relation to this, SK Chemicals' preferred shares surged to the upper price limit early in the trading session.

This content was produced with the assistance of AI translation services.